Interleukin 12 and Th1 responses in inflammatory bowel disease

This publication has 28 references indexed in Scilit:

• Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammation
  Immunology Today, 1997
• Glutamine depletion and increased gut permeability in nonanorectic, non-weight-losing tumor-bearing rats
  Gastroenterology, 1997
• Antibodies to interleukin 12 abrogate established experimental colitis in mice.
  The Journal of Experimental Medicine, 1995
• Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease
  Gastroenterology, 1995
• Experimental models of inflammatory bowel disease
  Gastroenterology, 1995
• Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR)
  Clinical and Experimental Immunology, 1995
• A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.
  Journal of Clinical Investigation, 1995
• Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.
  The Journal of Experimental Medicine, 1995
• Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis.
  The Journal of Experimental Medicine, 1995
• Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers.
  Gut, 1991